Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04763980 · ClinicalTrials.gov registry record · NA
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
A NA study of Prostate Carcinoma, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 3
- Study locations
NCT04763980: Recruiting NA study of Prostate Carcinoma, sponsored by University of California, San Francisco.
NCT04763980 is a NA study of Prostate Carcinoma that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 72 participants, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04763980, a NA study of Prostate Carcinoma, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial studies barriers to genetic testing in African American men with prostate cancer and whether tailored, culturally relevant genetic testing education provided by a community-based health coach is beneficial in improving knowledge, attitudes, and awareness of genetic testing. Information gained from this study, may help researchers better understand and learn more about how to increase access to germline genetic testing in underrepresented populations.
Primary Outcome
The consent rate for each cohort will be defined as proportion of patients enrolled in the study who agree to undergo germline genetic testing with Color genomics. The point estimate and 90% confidence interval will be provided.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Educational Intervention
- OTHER Genetic Testing
- OTHER ProGene Artificial Intelligence (AI) Platform
- OTHER Interviews
Study Locations (3)
California
- Zuckerberg San Francisco General Hospital - San Francisco
- San Francisco Veterans Administration Medical Center - San Francisco
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT04763980 shows while recruiting
NCT04763980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Survey Administration is the first listed.
NCT04763980 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04763980 about?
NCT04763980 is a clinical study titled "Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer". This clinical trial studies barriers to genetic testing in African American men with prostate cancer and whether tailored, culturally relevant genetic testing education provided by a community-based health coach is beneficial in improving knowledge, attitudes, and awareness of genetic testing. Infor...
What is the current status of trial NCT04763980?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2021-01-15. Estimated completion is 2027-03-31.
What conditions does trial NCT04763980 study?
This clinical trial studies the following conditions: Prostate Carcinoma.
What interventions are being tested in trial NCT04763980?
The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Genetic Testing (OTHER), ProGene Artificial Intelligence (AI) Platform (OTHER), Interviews (OTHER).
Who is sponsoring clinical trial NCT04763980?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04763980 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04763980's enrollment target sits among peer trials
72 36th of 59 higher than 24 of 59 other Prostate Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
RECRUITING · NA
-
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
RECRUITING · NA
-
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
RECRUITING · NA
-
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy
RECRUITING · NA
-
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
RECRUITING · NA
-
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI